AstraZeneca PLC
AZN 89.10 (0.72%) 0.64
Health Care
Pharmaceuticals
Quality Checklist 5/8
ROIC > 10%
Debt/Equity < 1
Net Margin > 10%
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
Current Ratio > 1
Quick Ratio > 1
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $276.21(B)
EV: $300.27(B)
Total Equity: $45.97(B)
Earnings date: Feb-10-2026
P/E: 29.39
Forward P/E: 19.32
P/FCF: 21.83
P/S: 4.75
P/B: 6.02
EPS: $3.0
EPS (fwd): $4.6
FCF/share: $4.1
Revenue/share: $18.8
Book value/share: $14.8
ROIC: 12.5%
ROA: 8.6%
ROE: 21.7%
Debt/Equity: 0.71
Current Ratio: 0.90
Gross margin: 83.3%
Operating margin: 22.0%
Net margin: 16.2%
Dividend/share: $1.6
Div. yield: 1.76%
TTM Financials
Income (TTM)
Revenue$58.13(B)
Gross profit$48.40(B)
EBITDA$20.42(B)
Net income$9.40(B)
Gross margin83.3%
Operating margin22.0%
Net margin16.2%
Shares outstanding3.10(B)
Balance sheet
Total assets$114.46(B)
Current assets$29.94(B)
Total liabilities$68.48(B)
Current liabilities$34.05(B)
Cash & Short-term inv.$8.18(B)
Long-term debt$24.70(B)
Total intangibles$59.41(B)
PP&E$13.78(B)
Cash flow (TTM)
FCF$12.66(B)
CapEx$-2.48(B)
Dividends paid$-4.97(B)
Stock issued$40.00(M)
Stock repurchased$-508.00(M)
Stock-based comp.$660.00(M)
Debt issued$819.00(M)
Debt repaid$-412.00(M)